Ads
related to: COVID-19 testing
Search results
QUIDELORTHO CORPORATION (NASDAQ: QDEL) DEADLINE ALERT: Bernstein Liebhard LLP Reminds QuidelOrtho...
Morningstar· 4 days agoDo you, or did you, own shares of QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ: QDEL)? Did you lose money in your investment in QuidelOrtho Corporation? Bernstein Liebhard LLP, a ...
QDEL INVESTOR ALERT: Securities Fraud Class Action Filed After QuidelOrtho (QDEL) Reports Disastrous...
Morningstar· 3 days agoSAN FRANCISCO, April 22, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges QuidelOrtho Corporation (NASDAQ: QDEL) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 18, 2022 – Apr. 1, 2024Lead Plaintiff Deadline
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 6 hours agoSAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- DiCello Levitt LLP announces that purchasers or acquirers of QuidelOrtho Corporation f/k/a Quidel Corporation (“QuidelOrtho” or the “Company”) (NASDAQ: QDEL) common stock between February 18, 2022
Roche Dx Revenues Down 6 Percent in Q1 on Lower COVID Test Sales as Base Business Rises
GenomeWeb News· 2 days agoThis story has been updated with comments from Roche's Q1 earnings call. NEW YORK – Roche on Wednesday reported its diagnostics sales in the first quarter fell 6 percent year over year to CHF ...
Roche Q1 Sales Down, Confirms FY24 View; Stock Down
RTT News· 2 days agoShares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook.
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with...
Benzinga· 4 days agoAttorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against QuidelOrtho ("QuidelOrtho" ...
Labcorp Acquiring Invitae Assets for $239M, Posts 5 Percent Rise in Q1 Revenues
GenomeWeb News· 15 hours agoLaboratory Corporation of America said after the close of markets Wednesday that it has been chosen as the winning bidder to acquire assets of genetic testing firm Invitae for $239 million.
Unlocking Q1 Potential of Quest Diagnostics (DGX): Exploring Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 4 days agoLooking beyond Wall Street's top -and-bottom-line estimate forecasts for Quest Diagnostics (DGX),...
MTA suspends 11 Long Island Rail Road workers for submitting fake COVID-19 vaccination cards issued...
Newsday· 1 day agoThe Metropolitan Transportation Authority has fired one Metro-North Railroad employee and suspended...
Roche Sales Decline in Last Quarter of Pandemic Impact
Bloomberg· 2 days agoRoche Holding AG’s sales fell in the first quarter, held down by a strong Swiss franc and a lack of...